Exicure Inc Stock, NASDAQ:XCUR
2430 North Halsted Street, Suite 410, Chicago, Illinois 60614
United States of America
Number of Employees: 63
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.